Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease

ApoE4 genotype is the most prevalent and also clinically most important risk factor for late-onset Alzheimer’s disease (AD). Available evidence suggests that the root cause for this increased risk is a trafficking defect at the level of the early endosome. ApoE4 differs from the most common ApoE3 is...

Full description

Bibliographic Details
Main Authors: Xunde Xian, Theresa Pohlkamp, Murat S Durakoglugil, Connie H Wong, Jürgen K Beck, Courtney Lane-Donovan, Florian Plattner, Joachim Herz
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2018-10-01
Series:eLife
Subjects:
NHE
Online Access:https://elifesciences.org/articles/40048
id doaj-56ac5602a3b543ba97edca746b7d6a70
record_format Article
spelling doaj-56ac5602a3b543ba97edca746b7d6a702021-05-05T16:15:23ZengeLife Sciences Publications LtdeLife2050-084X2018-10-01710.7554/eLife.40048Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s diseaseXunde Xian0https://orcid.org/0000-0003-3059-1254Theresa Pohlkamp1Murat S Durakoglugil2https://orcid.org/0000-0003-4483-8166Connie H Wong3https://orcid.org/0000-0002-6452-7966Jürgen K Beck4Courtney Lane-Donovan5https://orcid.org/0000-0001-9504-8346Florian Plattner6https://orcid.org/0000-0002-3150-1866Joachim Herz7https://orcid.org/0000-0002-8506-3400Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United StatesDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United StatesDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United StatesDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United StatesJkb Consult Inc SPRL, Brussels, BelgiumDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United StatesCenter for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United States; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, United StatesDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, United States; Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, United States; Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, United States; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, United StatesApoE4 genotype is the most prevalent and also clinically most important risk factor for late-onset Alzheimer’s disease (AD). Available evidence suggests that the root cause for this increased risk is a trafficking defect at the level of the early endosome. ApoE4 differs from the most common ApoE3 isoform by a single amino acid that increases its isoelectric point and promotes unfolding of ApoE4 upon endosomal vesicle acidification. We found that pharmacological and genetic inhibition of NHE6, the primary proton leak channel in the early endosome, in rodents completely reverses the ApoE4-induced recycling block of the ApoE receptor Apoer2/Lrp8 and the AMPA- and NMDA-type glutamate receptors that are regulated by, and co-endocytosed in a complex with, Apoer2. Moreover, NHE6 inhibition restores the Reelin-mediated modulation of excitatory synapses that is impaired by ApoE4. Our findings suggest a novel potential approach for the prevention of late-onset AD.https://elifesciences.org/articles/40048neurodegenerationsynaptic plasticityendosomerecyclingNHE
collection DOAJ
language English
format Article
sources DOAJ
author Xunde Xian
Theresa Pohlkamp
Murat S Durakoglugil
Connie H Wong
Jürgen K Beck
Courtney Lane-Donovan
Florian Plattner
Joachim Herz
spellingShingle Xunde Xian
Theresa Pohlkamp
Murat S Durakoglugil
Connie H Wong
Jürgen K Beck
Courtney Lane-Donovan
Florian Plattner
Joachim Herz
Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
eLife
neurodegeneration
synaptic plasticity
endosome
recycling
NHE
author_facet Xunde Xian
Theresa Pohlkamp
Murat S Durakoglugil
Connie H Wong
Jürgen K Beck
Courtney Lane-Donovan
Florian Plattner
Joachim Herz
author_sort Xunde Xian
title Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
title_short Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
title_full Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
title_fullStr Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
title_full_unstemmed Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
title_sort reversal of apoe4-induced recycling block as a novel prevention approach for alzheimer’s disease
publisher eLife Sciences Publications Ltd
series eLife
issn 2050-084X
publishDate 2018-10-01
description ApoE4 genotype is the most prevalent and also clinically most important risk factor for late-onset Alzheimer’s disease (AD). Available evidence suggests that the root cause for this increased risk is a trafficking defect at the level of the early endosome. ApoE4 differs from the most common ApoE3 isoform by a single amino acid that increases its isoelectric point and promotes unfolding of ApoE4 upon endosomal vesicle acidification. We found that pharmacological and genetic inhibition of NHE6, the primary proton leak channel in the early endosome, in rodents completely reverses the ApoE4-induced recycling block of the ApoE receptor Apoer2/Lrp8 and the AMPA- and NMDA-type glutamate receptors that are regulated by, and co-endocytosed in a complex with, Apoer2. Moreover, NHE6 inhibition restores the Reelin-mediated modulation of excitatory synapses that is impaired by ApoE4. Our findings suggest a novel potential approach for the prevention of late-onset AD.
topic neurodegeneration
synaptic plasticity
endosome
recycling
NHE
url https://elifesciences.org/articles/40048
work_keys_str_mv AT xundexian reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT theresapohlkamp reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT muratsdurakoglugil reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT conniehwong reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT jurgenkbeck reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT courtneylanedonovan reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT florianplattner reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
AT joachimherz reversalofapoe4inducedrecyclingblockasanovelpreventionapproachforalzheimersdisease
_version_ 1721459423111544832